KeepCalm: Managing stress during the COVID-19 Pandemic
The coronavirus disease 2019 (COVID-19) pandemic caused a global, unprecedented crisis that involved public health, economic system, and society in general, affecting populations all over the world.
As a consequence, people had to face not only the health emergency and the economic crisis but also the insecurity of the future and the fear for their health and employment
This clinical study was performed to investigate the ability of KeepCalm (Limosilactobacillus reuteri PBS072 and Bifidobacterium breve BB077) in supporting 33 healthy adults, working at a university, in stress management.
The efficacy of the tested strains in influencing the stress response, in terms of mood and sleep behavior, was assessed using the following validated questionnaires: Profile of Mood State (POMS) and Pittsburgh Sleep Quality Index (PSQI).
As demonstrated in this clinical study, KeepCalm showed a remarkable effect on stress management by improving the quality of sleep and the mood.
Discover more in this clinical study!
February 13th, 2023